Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silverman

Showing results (21-30 of 14,370) with videos related to

Pageof 1,437
Sort By:
Physical Therapy|September 1, 1982
Quadriceps femoris muscle assist orthosis in Duchenne muscular dystrophyI M Siegel, O Silverman, M Silverman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 26, 2002
Clinical research is dead; long live clinical researchMelvin Silverman
Lab Animal|May 31, 2001
An adequate av?J Silverman
Lab Animal|May 31, 2001
Ethicist or Bleeding HeartJ Silverman
Lab Animal|May 31, 2001
Is a "best guess" good enough?J Silverman
Lab Animal|November 1, 2001
Maximizing use of animals--but without a protocol?J Silverman
Cleveland Clinic Journal of Medicine|May 23, 2002
Hypothermia in a homeless manDavid Silverman
ASHA|August 1, 1990
Marketing as a public serviceM Silverman
Biotechnology Healthcare|April 6, 2012
Setting the Bar Higher For Off-Label Use of Biologics: Off-label use of biologics is common as physicians strive for optimal treatment. Patients want whatever works. Drug makers want expanded labeling, but payers chafe at the lack of efficacy data. Is there an answer to this conundrum?Ed Silverman
Biotechnology Healthcare|April 6, 2012
Creating a pathway over the regulatory chasm: a fresh startEd Silverman
Pageof 1,437

Showing results (21-30 of 14,370) with videos related to

Sort By:
Pageof 1,437
Physical Therapy|September 1, 1982
Quadriceps femoris muscle assist orthosis in Duchenne muscular dystrophyI M Siegel, O Silverman, M Silverman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 26, 2002
Clinical research is dead; long live clinical researchMelvin Silverman
Lab Animal|May 31, 2001
An adequate av?J Silverman
Lab Animal|May 31, 2001
Ethicist or Bleeding HeartJ Silverman
Lab Animal|May 31, 2001
Is a "best guess" good enough?J Silverman
Lab Animal|November 1, 2001
Maximizing use of animals--but without a protocol?J Silverman
Cleveland Clinic Journal of Medicine|May 23, 2002
Hypothermia in a homeless manDavid Silverman
ASHA|August 1, 1990
Marketing as a public serviceM Silverman
Biotechnology Healthcare|April 6, 2012
Setting the Bar Higher For Off-Label Use of Biologics: Off-label use of biologics is common as physicians strive for optimal treatment. Patients want whatever works. Drug makers want expanded labeling, but payers chafe at the lack of efficacy data. Is there an answer to this conundrum?Ed Silverman
Biotechnology Healthcare|April 6, 2012
Creating a pathway over the regulatory chasm: a fresh startEd Silverman
Pageof 1,437